Percutaneous coronary intervention (PCI) performs better than optical medical therapy (OMT) in improving quality of life (QoL), angina frequency, and the Seattle Angina Questionnaire (SAQ) summary score in patients with a single chronic total coronary occlusion (CTO), reports a study.
Some 518 patients with a single CTO and no other significant coronary lesion were identified from two randomized controlled trials, EUROCTO and DECISION-CTO, which had compared PCI with OMT. The randomization to PCI or OMT was 1:1 in DECISION and 2:1 in EUROCTO.
The investigators assessed clinical status using the SAQ summary score at baseline and after 12 months. They also monitored clinical events for 3 years.
Most patients (92.2 percent) underwent PCI successfully. Intention-to-treat analysis revealed the superiority of PCI to OMT for the change of angina frequency scores between baseline and follow-up (12.2 vs 8.6; p=0.009), QoL (19.5 vs 11.3; p<0.001), and the SAQ summary score (13.8 vs 8.5; p<0.001).
“For physical limitation, the difference was just at the level of the Bonferroni correction for multiple tests (p=0.01),” the investigators said.
A wide variability of changes was observed in SAQ scores. For QoL, a low baseline score and the assignment to PCI were major determinants for a significant improvement. On the other hand, gender, diabetes, or lesion complexity showed no significant influence.
Furthermore, cardiac death or nonfatal myocardial infarction were comparable between groups during a mean follow-up of 3.1 years (OMT vs PCI: 2.7 percent vs 5.1 percent; p=0.17). Likewise, the rates of stroke or hospitalization for bleeding showed no significant between-group difference, and only target lesion revascularizations were more frequent in the OMT group (18.8 percent vs 10.6 percent; p=0.005).
“In this post hoc analysis … PCI achieved better improvement in QoL, angina frequency, and the SAQ summary score than OMT with no signal of excess harm regarding clinical endpoints,” the investigators said.